Case based Panel Discussion: 49-year-old alcoholic cirrhosis (MELD 28); Recipient B+; Donor A-; IgG anti-A 512; IgM anti-A 256

Sub-topics:
1. Pre-transplant risk stratification & significance of antibody titers (IgG/IgM)
2. Desensitization protocols: Rituximab, plasmapheresis, IVIG, bortezomib
3. Perioperative immunosuppression: induction & maintenance strategies
4. Monitoring antibody titers – thresholds for proceeding
5. Intra-operative considerations – graft selection, ischemia time
6. Post-operative care: infection risks vs rejection control
7. Rescue strategies in refractory AMR after ABOi Liver Transplantation
8. Long-term graft survival and quality of life